Back to Home

ICON plc

NASDAQ: ICLR $172.99 USD~$15B MCAP

ICON plc is one of the world's largest clinical research organizations (CROs), providing outsourced drug development services to pharmaceutical, biotechnology, and medical device companies. ICON announced a strategic technology partnership with Microsoft in 2026 to accelerate AI-driven clinical trial design and execution.

Company Info

Sector:Clinical Research Organization / Drug Development Services
Headquarters:Dublin, Ireland
Founded:1990

Upcoming Milestones & Key Dates

Q2 2026
Corporate

Q1 2026 earnings call

Recent News

Industry UpdateFierce Biotech

Icon names Microsoft tech partner as Q1 results grow analyst confidence

Irish CRO giant ICON this week made Microsoft its technology partner as the organization advances its plan to increase investment in AI over the next three years. | Irish CRO giant Icon this week made Microsoft its technology partner as the organization advances its plan to increase investment in AI over the next three years. Microsoft’s Copilot and data infrastructure will be implemented enterpri

Leadership Team

Barry Balfe

Chief Executive Officer (effective October 1, 2025)

Careers & Job Openings

See all open roles

Multiple Departments
See careers page
Apply Now